Phenotypic psychiatric characterization of children with Williams syndrome and response of those with ADHD to methylphenidate treatment

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 159 B, Issue 1, 2012, Pages 13-20

  Green, Tamar ^a,b,c   Avda, Sarit ^b   Dotan, Inbar ^c   Zarchi, Omer ^a,c   Basel Vanagaite, Lina ^a,d   Zalsman, Gil ^a,e   Weizman, Abraham ^a,e   Gothelf, Doron ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEER YAAKOV MENTAL HEALTH CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^e GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

ADHD; Anxiety disorders; Methylphenidate; Obsessive compulsive symptoms; Williams syndrome

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ANXIETY DISORDER; APPETITE DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMPULSION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; IRRITABILITY; LONGITUDINAL STUDY; MALE; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PHENOTYPE; PHOBIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SIDE EFFECT; STEREOTYPY; WILLIAMS BEUREN SYNDROME;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METHYLPHENIDATE; OBSESSIVE-COMPULSIVE DISORDER; PHENOTYPE; SEROTONIN UPTAKE INHIBITORS; STEREOTYPED BEHAVIOR; WILLIAMS SYNDROME;

EID: 83755172087     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31247     Document Type: Article

References (44)

1. Bawden HN, MacDonald GW, Shea S. 1997. Treatment of children with Williams syndrome with methylphenidate. J Child Neurol 12(4): 248-252.
2. Bayes M, Magano LF, Rivera N, Flores R, Perez Jurado LA. 2003. Mutational mechanisms of Williams-Beuren syndrome deletions. Am J Hum Genet 73: 131-151.
3. Beuren AJ, Schulze C, Eberle P, Harmjanz D, Apitz J. 1964. The syndrome of supravalvular aortic stenosis, peripheral pulmonary stenosis, mental retardation and similar facial appearance. Am J Cardiol 13: 471-483.
4. Dekker MC, Koot HM. 2003. DSM-IV disorders in children with borderline to moderate intellectual disability. I: prevalence and impact. J Am Acad Child Adolesc Psychiatry 42(8): 915-922.
5. Doyle TF, Bellugi U, Korenberg JR, Graham J. 2004. "Everybody in the world is my friend" hypersociability in young children with Williams syndrome. Am J Med Genet Part A 124A(3): 263-273.
6. Dykens EM. 2003. Anxiety, fears, and phobias in persons with Williams syndrome. Dev Neuropsychol 23(1-2): 291-316.
7. Dykens EM, Rosner B. 1999. Refining behavioral phenotypes: Personality-motivation in Williams and Prader-Willi syndromes. Am J Ment Retard 104: 158-169.
8. Dykens EM, Leckman JF, Cassidy SB. 1996. Obsessions and compulsions in Prader-Willi syndrome. J Child Psychol Psychiatry 37(8): 995-1002.
9. Dykens EM, Rosner BA, Ly T, Sagun J. 2005. Music and anxiety in Williams syndrome: A harmonious or discordant relationship? Am J Ment Retard 110(5): 346-358.
10. Einfeld SL, Tonge BJ, Florio T. 1997. Behavioral and emotional disturbance in individuals with Williams syndrome. Am J Ment Retard 102(1): 45-53.
11. Einfeld SL, Tonge BJ, Rees VW. 2001. Longitudinal course of behavioral and emotional problems in Williams syndrome. Am J Ment Retard 106(1): 73-81.
12. Feinstein C. 2009. Stranded, part II: Velocardiofacial syndrome, behavioral neurogenetics, and the study of developmental psychopathology. J Am Acad Child Adolesc Psychiatry 48(11): 1049-1050.
13. Ghuman JK, Aman MG, Lecavalier L, Riddle MA, Gelenberg A, Wright R, Rice S, Ghuman HS, Fort C. 2009. Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders. J Child Adolesc Psychopharmacol 19(4): 329-339.
14. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. 1989. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46(11): 1006-1011.
15. Gothelf D, Presburger G, Zohar AH, Burg M, Nahmani A, Frydman M, Shohat M, Inbar D, Aviram-Goldring A. Yeshaya J, et al. 2004. Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am J Med Genet Part B 126B(1): 99-105.
16. Gothelf D, Farber N, Raveh E, Apter A, Attias J. 2006. Hyperacusis in Williams syndrome: Characteristics and associated neuroaudiologic abnormalities. Neurology 66(3): 390-395.
17. Gothelf D, Feinstein C, Thompson T, Gu E, Penniman L, Van Stone E, Kwon H, Eliez S, Reiss AL. 2007. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 164(4): 663-669.
18. Gothelf D, Goraly O, Avni S, Stawski M, Hartmann I, Basel-Vanagaite L, Apter A. 2008. Psychiatric morbidity with focus on obsessive-compulsive disorder in an Israeli cohort of adolescents with mild to moderate mental retardation. J Neural Transm 115(6): 929-936.
19. Haas BW, Mills D, Yam A, Hoeft F, Bellugi U, Reiss A. 2009. Genetic influences on sociability: Heightened amygdala reactivity and event-related responses to positive social stimuli in Williams syndrome. J Neurosci 29(4): 1132-1139.
20. Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, Kronk R, Delahunty C, Hessl D, Visootsak J, et al. 2009. Advances in the treatment of fragile X syndrome. Pediatrics 123(1): 378-390.
21. Handen BL, Breaux AM, Gosling A, Ploof DL, Feldman H. 1990. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder. Pediatrics 86(6): 922-930.
22. Hedges DW, Brown BL, Shwalb DA. 2009. A direct comparison of effect sizes from the clinical global impression-improvement scale to effect sizes from other rating scales in controlled trials of adult social anxiety disorder. Hum Psychopharmacol 24(1): 35-40.
23. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. 1997. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36(7): 980-988.
24. Kennedy JC, Kaye DL, Sadler LS. 2006. Psychiatric diagnoses in patients with Williams syndrome and their families. Jefferson J Psychiatry 20: 22-31.
25. Klein AJ, Armstrong BL, Greer MK, Brown FR III. 1990. Hyperacusis and otitis media in individuals with Williams syndrome. J Speech Hear Disord 55(2): 339-344.
26. Klein-Tasman BP, Mervis CB. 2003. Distinctive personality characteristics of 8-, 9-, and 10-year-olds with Williams syndrome. Dev Neuropsychol 23(1-2): 269-290.
27. Last CG, Perrin S, Hersen M, Kazdin AE. 1996. A prospective study of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 35(11): 1502-1510.
28. Levine K, Wharton R. 2000. Williams syndrome and happiness. Am J Ment Retard 105(5): 363-371.
29. Leyfer OT, Woodruff-Borden J, Klein-Tasman BP, Fricke JS, Mervis CB. 2006. Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome. Am J Med Genet Part B 141B(6): 615-622.
30. Leyfer O, Woodruff-Borden J, Mervis CB. 2009. Anxiety disorders in children with Williams syndrome, their mothers, and their siblings: Implications for the etiology of anxiety disorders. J Neurodev Disord 1(1): 4-14.
31. Mervis CB, Klein-Tasman BP. 2000. Williams syndrome: Cognition, personality, and adaptive behavior. Ment Retard Dev Disabil Res Rev 6(2): 148-158.
32. Mervis CB, Morris CA, Klein-Tasman BP, Bertrand J, Kwitny S, Appelbaum LG, Rice CE. 2003. Attentional characteristics of infants and toddlers with Williams syndrome during triadic interactions. Dev Neuropsychol 23(1-2): 243-268.
33. Meyer-Lindenberg A, Hariri AR, Munoz KE, Mervis CB, Mattay VS, Morris CA, Berman KF. 2005. Neural correlates of genetically abnormal social cognition in Williams syndrome. Nat Neurosci 8(8): 991-993.
34. Morris CA. 2010. The behavioral phenotype of Williams syndrome: A recognizable pattern of neurodevelopment. Am J Med Genet Part C 154C(4): 427-431.
35. Morris CA, Demsey SA, Leonard CO, Dilts C, Blackburn BL. 1988. Natural history of Williams syndrome: Physical characteristics. J Pediatr 113(2): 318-326.
36. National Institute of Mental Health. 1985. CGI (Clinical Global Impressions Scale)-NIMH. Psychopharmacol Bull 21: 839-844.
37. Power TJ, Blum NJ, Jones SM, Kaplan PE. 1997. Brief report: Response to methylphenidate in two children with Williams syndrome. J Autism Dev Disord 27(1): 79-87.
38. Rojahn J, Matlock ST, Tasse MJ. 2000. The stereotyped behavior scale: Psychometric properties and norms. Res Dev Disabil 21(6): 437-454.
39. Rowles BM, Findling RL. 2010. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders. Dev Disabil Res Rev 16(3): 273-282.
40. Rutter M. 2008. Rutter's Child and Adolescent Psychiatry. Sugden M, editor. UK: Blackwell Publishing.
41. Schubert C. 2009. The genomic basis of the Williams-Beuren syndrome. Cell Mol Life Sci 66(7): 1178-1197.
42. Shanee N, Apter A, Weizman A. 1997. Psychometric properties of the K-SADS-PL in an Israeli adolescent clinical population. Isr J Psychiatry Relat Sci 34(3): 179-186.
43. Wechsler D. 1991. Wechsler Intelligence Scale for Children. 3rd edition Manual. San Antonio, Tex: Psychological Corp.
44. Woodruff-Borden J, Kistler DJ, Henderson DR, Crawford NA, Mervis CB. 2010. Longitudinal course of anxiety in children and adolescents with Williams syndrome. Am J Med Genet Part C 154C(2): 277-290.